Scinai Immunotherapeutics (SCNI) Accumulated Expenses (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Scinai Immunotherapeutics (SCNI) has disclosed Accumulated Expenses for 2 consecutive years, with $318000.0 as the latest value for Q4 2025.

• Quarterly Accumulated Expenses rose 25.2% to $318000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $318000.0 through Dec 2025, up 25.2% year-over-year, with the annual reading at $318000.0 for FY2025, 25.2% up from the prior year.
• Accumulated Expenses hit $318000.0 in Q4 2025 for Scinai Immunotherapeutics, up from $254000.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $318000.0 in Q4 2025 to a low of $254000.0 in Q4 2024.

Peer Comparison